The Anti-DNA Antibodies: Their Specificities for Unique DNA Structures and Their Unresolved Clinical Impact-A System Criticism and a Hypothesis

Front Immunol. 2022 Jan 11:12:808008. doi: 10.3389/fimmu.2021.808008. eCollection 2021.

Abstract

Systemic lupus erythematosus (SLE) is diagnosed and classified by criteria, or by experience, intuition and traditions, and not by scientifically well-defined etiology(ies) or pathogenicity(ies). One central criterion and diagnostic factor is founded on theoretical and analytical approaches based on our imperfect definition of the term "The anti-dsDNA antibody". "The anti-dsDNA antibody" holds an archaic position in SLE as a unique classification criterium and pathogenic factor. In a wider sense, antibodies to unique transcriptionally active or silent DNA structures and chromatin components may have individual and profound nephritogenic impact although not considered yet - not in theoretical nor in descriptive or experimental contexts. This hypothesis is contemplated here. In this analysis, our state-of-the-art conception of these antibodies is probed and found too deficient with respect to their origin, structural DNA specificities and clinical/pathogenic impact. Discoveries of DNA structures and functions started with Miescher's Nuclein (1871), via Chargaff, Franklin, Watson and Crick, and continues today. The discoveries have left us with a DNA helix that presents distinct structures expressing unique operations of DNA. All structures are proven immunogenic! Unique autoimmune antibodies are described against e.g. ssDNA, elongated B DNA, bent B DNA, Z DNA, cruciform DNA, or individual components of chromatin. In light of the massive scientific interest in anti-DNA antibodies over decades, it is an unexpected observation that the spectrum of DNA structures has been known for decades without being implemented in clinical immunology. This leads consequently to a critical analysis of historical and contemporary evidence-based data and of ignored and one-dimensional contexts and hypotheses: i.e. "one antibody - one disease". In this study radical viewpoints on the impact of DNA and chromatin immunity/autoimmunity are considered and discussed in context of the pathogenesis of lupus nephritis.

Keywords: DNA structures; anti-DNA antibodies; classification criteria; pathogenicity; systemic lupus erythematosus.

Publication types

  • Review

MeSH terms

  • Antibodies, Antinuclear / immunology*
  • Antibody Formation / immunology
  • Antibody Specificity / immunology
  • Autoimmunity
  • Chromatin / chemistry
  • Chromatin / immunology
  • Cross Reactions / immunology
  • DNA / chemistry
  • DNA / immunology
  • Disease Susceptibility / immunology
  • Humans
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / etiology*
  • Lupus Erythematosus, Systemic / therapy
  • Nucleic Acid Conformation
  • Peptides / immunology
  • Phospholipids / immunology
  • Proteins

Substances

  • Antibodies, Antinuclear
  • Chromatin
  • Peptides
  • Phospholipids
  • Proteins
  • anti-dsDNA autoantibody
  • DNA